Custom service
Linkers and Spacers
Insert cleavable or non-cleavable linkers and spacers of defined length
Linkers and Spacers supports programmes that insert cleavable or non-cleavable linkers and spacers of defined length. In a typical engagement we plan the PEG and alkyl spacers (C2–C24) route first, confirm compatibility with cleavable motifs (Val-Cit, disulfide, hydrazone), and release linker-modified construct with spacer confirmation on a 2–5 weeks schedule.
Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep PEG and alkyl spacers (C2–C24) as the primary option and hold cleavable motifs (Val-Cit, disulfide, hydrazone) in reserve, so that scale-up never depends on an unproven step.
Tuning payload-to-carrier distance in conjugates
Protease-cleavable prodrug linkers
Linker chemistries requiring licensed proprietary IP
Modifications requiring radiological or BSL-3 containment
Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.
Service Highlights
- PEG and alkyl spacers (C2–C24) as the default route, with cleavable motifs (Val-Cit, disulfide, hydrazone) held as a proven fallback
- Click-ready bifunctional linkers worked into the design where the application requires it
- Modification sites are mapped on the sequence and confirmed by MS/MS before release
- Analytical confirmation of every intermediate before the final release
- Modified and unmodified species are separated and quantified, not just reported
- Linker-modified construct with spacer confirmation delivered with a complete conjugation or synthesis certificate
How the work runs
Sequence & modification map
We annotate every modification site, protection strategy and analytical target before synthesis starts.
Solid-phase assembly
The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.
Modification chemistry
Post-synthesis steps — PEG and alkyl spacers (C2–C24), cleavable motifs (Val-Cit, disulfide, hydrazone) — are run under conditions validated on a test cleavage.
Cleavage & purification
Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.
Analytical release
Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.
Documentation
Linker-modified construct with spacer confirmation is released with the batch record and analytical package after QC sign-off.
Specifications & timeline
- Turnaround
- 2–5 weeks
- Typical scale
- 0.5 mg – 1 g modified peptide
- Chemistry options
- PEG and alkyl spacers (C2–C24); cleavable motifs (Val-Cit, disulfide, hydrazone); click-ready bifunctional linkers
- Deliverable
- Linker-modified construct with spacer confirmation
- QC package
- HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
- Shipping
- Ambient or blue ice as stability data dictate
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.